Jeff Goater Insider Trading $SURF Surface Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeff Goater.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeff Goater. Jeff Goater is Director in VACCINEX, INC. ($VCNX) and Chief Financial Officer in Voyager Therapeutics, Inc. ($VYGR) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Chief Executive Officer in Surface Oncology, Inc. ($SURF) and Director in Surface Oncology, Inc. ($SURF).

Jeff Goater in Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jeff Goater: Director, Chief Executive Officer
Holdings: 462,000 shares
Latest Transaction: Jun 11 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeff Goater in Surface Oncology, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, LOGC, SURF, VCNX, VYGR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	M	4.14	10,273	42,530	93,831
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	M	4.14	34,727	143,770	10,325
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	M	4.14	200,000	828,000	104,104
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Sell	S	7.61	15,273	116,226	257,000	272.3 K to 257 K (-5.61 %)
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Buy	M	4.14	10,273	42,530	272,273	262 K to 272.3 K (+3.92 %)
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Sell	S	7.66	234,727	1,798,619	262,000	496.7 K to 262 K (-47.25 %)
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Buy	M	4.14	34,727	143,770	496,727	462 K to 496.7 K (+7.52 %)
Jun 11 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Buy	M	4.14	200,000	828,000	462,000	262 K to 462 K (+76.34 %)
Apr 02 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	A	8.09	4,425	35,798	4,425
Apr 02 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	A	8.09	35,400	286,386	35,400
Apr 02 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	A	8.09	15,000	121,350	15,000
Apr 02 2021	SURF	Surface Oncology, ...	Goater Jeff	Director	Option Exercise	A	8.09	15,000	121,350	15,000
Feb 09 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Option Exercise	M	3.18	2,500	7,950	247,000
Feb 09 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Sell	S	12.50	2,500	31,250	262,000	264.5 K to 262 K (-0.95 %)
Feb 09 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Buy	M	3.18	2,500	7,950	264,500	262 K to 264.5 K (+0.95 %)
Feb 03 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Option Exercise	M	3.18	2,500	7,950	249,500
Feb 03 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Sell	S	10.69	2,500	26,718	262,000	264.5 K to 262 K (-0.95 %)
Feb 03 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Buy	M	3.18	2,500	7,950	264,500	262 K to 264.5 K (+0.95 %)
Jan 21 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Option Exercise	M	3.18	5,000	15,900	252,000
Jan 21 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Sell	S	13.00	5,000	65,000	262,000	267 K to 262 K (-1.87 %)
Jan 21 2021	SURF	Surface Oncology, ...	Goater Jeff	Chief Executive Off ...	Buy	M	3.18	5,000	15,900	267,000	262 K to 267 K (+1.91 %)

Page: 1